References
- Crowe RR. The genetics of panic disorder and agoraphobia. Psychiatr Dev 1985; 2(3): 171–85
- Weissman MM. The hidden patient: unrecognized panic disorder. J Clin Psychiatry 1990; 51(Suppl 11):5–8
- Johnson MR, Lydiard RB, Ballenger JC. Panic disorder: pathophysiology and drug treatment. Drugs 1995; 49(3):328–44
- Keller MB, Baker LA. The clinical course of panic disorder and depression. J Clin Psychiatry 1992; 53(Supp1 3):5–8
References
- Katon WJ, Von Korff M, Lin E. Panic disorder: relationship to high medical utilization. Am J Med 1992; 92(Suppl 1A):7–11S
- Eaton WW, Kessler RC, Wittchen HU, et al. Panic and panic disorder in the United States. Am J Psychiatry 1994; 151 (3):413–20
- Katon W, Vitaliano PP, Russo J, et al. Panic disorder: epidemiology in primary care. J Fam Pract 1986; 23(3):233–9
- Klerman GL, Weissman MM, Ouellette R, et al. Panic attacks in the community: social morbidity and health care utilization. JAMA 1991; 265(6):742–6
- Raj BA, Corvea MH, Dagon EM. The clinical characteristics of panic disorder in the elderly: a retrospective study. J Clin Psychiatry 1993; 54(4):150–5
- Weissman MM. Panic disorder: impact on quality of life. J Clin Psychiatry 1991; 52(Suppl 2):6–8
- Salvador-Carulla L, Segui J, Fernandez-Cano P, et al. Costs and offset effect in panic disorders. Br J Psychiatry 1995; 166 (Suppl 27):23–8
- Wheeler EO, White PD, Reed EW et al. Neurocirculatory asthenia (anxiety neurosis, effort syndrome, neurasthenia): a twenty year follow-up study of one hundred and seventy-three patients. JAMA 1950; 142(Mar 25):878–88
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Am Psychiatric Assn, 1994:395
- Liebowitz MR, Barlow DH. Panic disorder: the latest on diagnosis and treatment. J Pract Psych Behav Health 1995; 1(May):10–9
- Noyes R, Reich J, Clancy J, et al. Reduction in hypochondriasis with treatment of panic disorder. Br J Psychiatry 1986; 149:631–5 [Erratum, Br J Psychiatry 1987;150:273]
- Markowitz JS, Weissman MM, Ouellette R, et al. Quality of life in panic disorder. Arch Gen Psychiatry 1989; 46(11):984–92
- Chen YW, Dilsaver SC. Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area survey. Am J Psychiatry 1995; 152(2): 280–2
- Weissman MM, Klerman GL, Markowitz JS, et al. Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med 1989; 321(18):1209–14
- Fawcett J. Suicide risk factors in depressive disorders and in panic disorder. J Clin Psychiatry 1992; 53(Suppl 3):9–13
- Fleet RP, Dupuis G, Marchand A, et al. Panic disorder, chest pain and coronary artery disease: literature review. Can J Cardiol 1994; 10(8):827–34
- Chignon JM, Lepine JP, Ades J. Panic disorder in cardiac outpatients. Am J Psychiatry 1993; 150(5):780–5
- Bass C. Chest pain and breathless- ness: relationship to psychiatric illness. Am J Med 1992; 92(Suppl 1A):12–7S
- Walker EA, Roy-Byrne PP, Katon WJ, et al. Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease. Am J Psychiatry 1990; 147(12):1656–61
- Stewart WF, Shechter A, Liberman J. Physician consultation for headache pain and history of panic: results from a population-based study. Am J Med 1992; 92(Suppl 1A):35–40S
- Roy-Byrne PP. Integrated treatment of panic disorder. Am J Med 1992; 92 (Suppl 1A):49–54S
- Klerman GL. Treatments for panic disorder. J Clin Psychiatry 1992; 53(Suppl 3):14–9
- Beck AT. Cognitive approaches to panic disorder: theory and therapy. In: Rachman S, Maser JD, eds. Panic: psychological perspectives. Hillsdale, NJ: L Erlbaum Assoc, 1988:91–109
- Johnson MR, Lydiard RB, Ballenger JC. Panic disorder: pathophysiology and drug treatment. Drugs 1995; 49(3):328–44
- Ballenger JC. Medication discontinuation in panic disorder. J Clin Psychiatry 1992; 53(Suppl3):26–31
- Schatzberg AF, Ballenger JC. Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat. J Clin Psychiatry 1991; 52(Suppl 2):26–31
- Boyer W. Serotonin uptake inhibitors are superior to Imipramine and alprazolam in alleviating panic attacks: a metaanalysis. Int Clin Psychopharmacol 1995;10(1):45–9
- Schneier FR, Liebowitz MR, Davies SO, et al. Fluoxetine in panic disorder. J Clin Psychopharmacol 1990; 10(2): 119–21
- Louie AK, Lewis TB, Lannon RA. Use of low-dose fluoxetine in major depression and panic disorder. J Clin Psychiatry 1993; 54(11):435–8
- Oehrberg S, Christiansen PE, Behnke K, et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study. Br J Psychiatry 1995; 167(3):374–9
- Black DW, Wesner R, Bowers W, et al. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993;50(1):44–50
- Tesar GE, Rosenbaum JF, Pollack MH, et al. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry 1991;52(2):69–76
- Rickels K, Schweizer E, Weiss S, et al. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper. Arch Gen Psychiatry 1993; 50(1):61–8
- Shelton RC, Harvey DS, Stewart PM, et al. Alprazolam in panic disorder: a retrospective analysis. Prog Neuropsy- chopharmacol Biol Psychiatry 1993; 17(3): 423–34
- Fahy TJ, O'Rourke D, Brophy J, et al. The Galway Study of Panic Disorder I. Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial. J Affect Disord 1992; 25(1): 63–75 [Erratum, J Affect Disord 1992; 25(3):214]
- Mavissakalian MR, Perel JM. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships. Am J Psychiatry 1995; 152(5):673–82
- Modigh K, Westberg P, Eriksson E. Superiority of clomipramine over Imipramine in the treatment of panic disorder: a placebo-controlled trial. J Clin Psychopharmacol 1992; 12(4):251–61
- Guy S, Silke B. The electrocardiogram as a tool for therapeutic monitoring: a critical analysis. J Clin Psychiatry 1990;51(Suppl 12B):37–9
- Johnson MR, Lydiard RB, Ballenger JC. MAOIs in panic disorder and agoraphobia. In: Kennedy SH, ed. Clinical advances in monoamine oxidase inhibitor therapies. Washington, DC: Am Psychiatric Press, 1994:205–24